DRCR Protocol AC – Aflibercept vs. Bevacizumab with Deferred Aflibercept for Diabetic Macular Edema
Purpose of Study
To find out if starting with Eylea has better results than starting with the less expensive drug, Avastin, and only switching to Eylea if needed in patients who have diabetic macular edema.
- Study in follow-up phase only; Enrollment Complete
How to Contact Us
Principal Investigator: Shree Kurup, MD
Study Coordinator: Leslie Richards | 216-844-7934